Plexus jumps nearly 4% as buyers front-run late-April earnings catalyst
Plexus shares rose 3.86% to $210.31 as investors positioned ahead of the company’s fiscal Q2 2026 print due in late April. Momentum has been supported by strong Q1 results and upbeat Q2 guidance issued on January 28, including revenue guidance of $1.11–$1.15B and non-GAAP EPS guidance of $1.80–$1.95.
1) What’s moving PLXS today
Plexus (PLXS) traded higher Wednesday, up 3.86% to $210.31, in a move that appears tied to pre-earnings positioning rather than a fresh same-day corporate announcement. With the fiscal second quarter ending April 4, 2026 and results expected later in April, the stock’s rebound looks like a momentum bid into a near-term catalyst as investors reprice the probability of another solid quarter.
2) The setup: Q1 beat and bullish Q2 guide still in focus
The key reference point for the move remains Plexus’ fiscal Q1 2026 report and outlook issued January 28, 2026. Plexus reported Q1 revenue of $1.070 billion and non-GAAP EPS of $1.78, and guided Q2 revenue to $1.110–$1.150 billion with non-GAAP EPS of $1.80–$1.95, signaling continued sequential growth and improving demand/program ramps. Management also highlighted 22 manufacturing program wins representing $283 million in annualized revenue when fully ramped, reinforcing the narrative that new program conversions are driving the next leg of growth. (investor.plexus.com)
3) What investors will watch next
The next major data point is the upcoming earnings release targeted for late April 2026, with market calendars listing April 29, 2026 as the expected date. Traders will focus on whether Plexus delivers near the top end of its Q2 ranges, updates its fiscal 2026 growth outlook, and provides color on ramp timing across Aerospace/Defense and Healthcare/Life Sciences—the two sectors management previously flagged as robust growth contributors. (investing.com)